publisher of
- Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer. 2023
- Adult Cancer-Related Emergency Department Utilization: An Analysis of Trends and Outcomes From Emergency Departments in Maryland and New York.. JCO Oncology Practice. 19:e683-e695. 2023
- Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy.. JCO Precision Oncology. 6:e2000368. 2022
- Question Prompt List to Support Patient-Provider Communication in the Use of the 21-Gene Recurrence Test: Feasibility, Acceptability, and Outcomes. 2020
- When Cancer Centers Mislead Prospective Patients.. JCO Oncology Practice. 16:219-222. 2020
- Proposing a Bill of Rights for Patients With Cancer.. JCO Oncology Practice. 16:121-123. 2020
- Stochastic cancer-immune coevolution: Implications for cancer incidence and immunotherapeutic efficacy.. Journal of Clinical Oncology. 37:e14023-e14023. 2019
- GATA2 exosomal mRNA: A novel urine biomarker for the diagnosis of clinically significant prostate cancer.. Journal of Clinical Oncology. 37:18-18. 2019
- Feasibility of Wearable Physical Activity Monitors in Patients With Cancer.. JCO Clinical Cancer Informatics. 2:1-10. 2018
- Lessons in Integrating Shared Decision-Making Into Cancer Care. 2018
- Bidirectional Text Messaging to Monitor Endocrine Therapy Adherence and Patient-Reported Outcomes in Breast Cancer. 2017
- Role of Kindness in Cancer Care.. Journal of Oncology Practice. 13:744-750. 2017
- How a Child With Cancer Moved From Vulnerability to Resilience.. Journal of Clinical Oncology. 35:3169-3171. 2017
- Feasibility of wearable physical activity monitors in cancer patients (PAMCaP).. Journal of Clinical Oncology. 35:6577-6577. 2017
- Promise of Wearable Physical Activity Monitors in Oncology Practice.. Journal of Oncology Practice. 13:82-89. 2017
- Quantifying the electronic medical record implementation to stabilization curve.. Journal of Clinical Oncology. 35:140-140. 2017
- Supporting the Supporters: What Family Caregivers Need to Care for a Loved One With Cancer. 2017
- Assessing Patient-Centered Communication in Cancer Care: Measures for Surveillance of Communication Outcomes.. Journal of Oncology Practice. 12:1198-1202. 2016
- What Adult Cancer Care Can Learn From Pediatrics.. Journal of Oncology Practice. 12:765-767. 2016
- Managing the Clues in Cancer Care. 2016
- Measurement of spatial and antibody-based PD-L1 heterogeneity in non-small cell lung cancer.. Journal of Clinical Oncology. 34:9040-9040. 2016
- New Diagnosis Bundle: Improving Care Delivery for Patients With Newly Diagnosed Cancer.. Journal of Oncology Practice. 12:404-406. 2016
- The Branding of Palliative Care. 2016
- A global genomic and small molecule inhibitor interrogation of KIT mutant melanoma to reveal underlying biology and novel molecular targets.. Journal of Clinical Oncology. 33:9039-9039. 2015
- Discovery and disclosure of incidental genetic information obtained through high throughput sequencing.. Journal of Clinical Oncology. 33:e17779-e17779. 2015
- Consultations between patients with breast cancer and surgeons: a pathway from patient-centered communication to reduced hopelessness.. Journal of Clinical Oncology. 31:351-358. 2013
- Longitudinal relationship between inflammatory markers and patient-reported symptom severity during induction therapy for multiple myeloma.. Journal of Clinical Oncology. 30:9083-9083. 2012
- Predictive value of baseline serum MIP-1 and CRP on symptom burden and tumor response to induction therapy in patients with multiple myeloma.. Journal of Clinical Oncology. 30:8091-8091. 2012
- Differential gene expression in liposarcoma: Insight into pathways for dedifferentiation?. Journal of Clinical Oncology. 30:10048-10048. 2012
- How to run survival-endpoint phase II trials with 25% to 40% fewer patients.. Journal of Clinical Oncology. 30:2544-2544. 2012
- Inflammatory markers and symptom burden in patients with multiple myeloma undergoing autologous stem cell transplantation.. Journal of Clinical Oncology. 30:9081-9081. 2012
- PTHrP(12-48) for the diagnosis of breast cancer bone metastasis.. Journal of Clinical Oncology. 30:e21039-e21039. 2012
- Results of a high-throughput screen to identify compounds that modulate VHL proteostasis.. Journal of Clinical Oncology. 30:369-369. 2012
- Therapeutic options in metastatic castration-resistant prostate cancer (mCRPC): A cost-effectiveness analysis.. Journal of Clinical Oncology. 30:e15154-e15154. 2012
- Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion. 2011
- Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. 2011
- Association of sTNF-R1 and the development of treatment-related symptoms in patients undergoing concurrent chemoradiation therapy for colorectal or esophageal cancer. Journal of Clinical Oncology. 27:3041-3041. 2009
- Breath analysis as a method for breast cancer early detection. Journal of Clinical Oncology. 26:1522-1522. 2008
- Racial differences in trust and lung cancer patients' perceptions of physician communication.. Journal of Clinical Oncology. 24:904-909. 2006
- Profile of daily life in children with brain tumors: an assessment of health-related quality of life. 2005
- Analysis of real-world data (RWD) on treatment (tx) sequencing in patients with advanced non-small cell lung cancer (aNSCLC).. Journal of Clinical Oncology. e20642-e20642. 2019
- Investigating racial differences in treatment responses through analysis of real-world data (RWD).. Journal of Clinical Oncology. e18141-e18141. 2019
- Onset of side effects and adherence to endocrine therapy in the Breast Cancer Endocrine Therapy Adherence (BETA) pilot study. Journal of Clinical Oncology. e18136-e18136. 2016
- The role of FGF signaling in VEGF-pathway targeted therapy resistance: Data from patients and model systems. Journal of Clinical Oncology. 386-386. 2013
- Fibroblast growth factor receptor 1 (FGFR1) expression and activation in clear cell renal cell carcinoma (ccRCC).. Journal of Clinical Oncology. e15015-e15015. 2011